Immunology, Microbiology & IBD

Guidelines


Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis


HLA-Cw*1202-B*5201-DRB1*1502 Haplotype Increases Risk for Ulcerative Colitis but Reduces Risk for Crohn's Disease


View All

Education & Meetings

Crohn's Disease Virtual Clinic: Alexander Visit 1


Nutrition Toolkit Series: Nutrition and Food Allergies


Protect Your Bottom Line & Achieve Excellence: The AGA Digestive Health Recognition Program Webinar


View All

Journal Articles & Editorials

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease


A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis


The Prevalence of Intestinal Parasites Is Not Greater Among Individuals With Irritable Bowel Syndrome: A Population-based Case-control Study


View All

Audio

CGH Podcast November 2014: Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis


Gastroenterology Podcast September 2014: Vedolizumab for Crohn’s Patients After TNF Therapy Has Failed


CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response


View All

IBD Resource Center

Pioneering research from the AGA journals on the biology and clinical management of IBD. Original research, reviews, multimedia and more. Visit the AGA Journals' IBD Resource Center.